Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pyridostigmine as Immunomodulator in HIV
NCT03312244Phase 2Suspended
- Sponsor
- Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
- Start
- Jul 2019
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pyridostigmine in human immunodeficiency virus infection (HIV), sponsored by Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Started Jul 2019; status: suspended.
02
Drugs
pyridostigmine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT03312244.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03312244.